LUAD-CSRS

1 paper2 findings

In silico1

Associations

2

Immunotherapy

mixedin silico1

1 study

LUAD-CSRS predicts immunotherapy in silico.
“difference of immune infiltration and response to immunotherapy in patients with high and low risk of LUAD were evaluated.”
In silicolung adenocarcinoma
Identification of cellular senescence-associated genes for predicting the diagnosis, prognosis and immunotherapy response in lung adenocarcinoma via a 113-combination machine learning framework
Discover oncology1 Apr 2025

More on Immunotherapy

Mortality

downin silico1

1 study

LUAD-CSRS predicts mortality in silico.
“We also confirmed that it was significantly associated with survival, immune cell infiltration, prognosis, and response to immunotherapy in LUAD patients.”
In silicolung adenocarcinoma
Identification of cellular senescence-associated genes for predicting the diagnosis, prognosis and immunotherapy response in lung adenocarcinoma via a 113-combination machine learning framework
Discover oncology1 Apr 2025

Latest

Discover Oncology2 Apr

Identification of cellular senescence-associated genes for predicting the diagnosis, prognosis and immunotherapy response in lung adenocarcinoma via a 113-combination machine learning framework

Computational studyLung adenocarcinoma